You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 22, December 10, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Medical Practice, Other
 •Cardiovascular System
 •Cardiovascular Disease/ Myocardial Infarction
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Socioeconomic Status and Coronary Heart Disease Risk Prediction

Kevin Fiscella, MD, MPH; Daniel Tancredi, PhD

JAMA. 2008;300(22):2666-2668.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Achieving the Healthy People 2010 goal of reducing health disparities has been challenging. Disparity in life expectancy by socioeconomic status (SES) has been increasing.1 Much of this disparity is attributable to higher cardiovascular mortality, particularly from coronary heart disease (CHD), among persons of lower SES. Disparities in CHD mortality result from multiple factors, including early life environment and material disadvantage,2 social and behavioral risk factors,3 access to care,4 and systematic underestimation of risk among persons with lower SES in clinical care. This Commentary addresses the importance of SES in CHD risk assessment.

Current risk-based intervention strategies ignore the independent contribution of SES to CHD and thus may contribute to increasing SES disparities. If CHD risk is better estimated among the poor, it could lead to increased statin use for cholesterol reduction and aspirin use for CHD prevention among this population, which may reduce . . . [Full Text of this Article]

Independent CHD Risk Factor

Author Affiliations: Departments of Family Medicine, Community & Preventive Medicine, and Oncology, University of Rochester, Rochester, New York (Dr Fiscella); and Department of Pediatrics, Center for Healthcare Policy and Research, University of California at Davis (Dr Tancredi).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.